THU0275 IL-6 Receptor (IL-6R) Blockade with Sarilumab Reduced Circulating Markers Related to Synovial Inflammation and Structural Damage in Patients with Rheumatoid Arthritis (RA) in A Phase 2 Study
Fiore, S., Boyapati, A., Hamon, S. C., van Adelsberg, J., Liu, M., Hamilton, J. D.Volume:
73
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2014-eular.3852
Date:
June, 2014
File:
PDF, 96 KB
english, 2014